Health CatalystHCAT
Market Cap: $441M
About: Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
Employees: 1,300
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
133,617% more call options, than puts
Call options by funds: $16M | Put options by funds: $12K
23% more repeat investments, than reductions
Existing positions increased: 64 | Existing positions reduced: 52
0% more funds holding in top 10
Funds holding in top 10: 2 [Q1] → 2 (+0) [Q2]
0% more ownership
Funds ownership: 86.35% [Q1] → 86.35% (+0%) [Q2]
8% less funds holding
Funds holding: 172 [Q1] → 159 (-13) [Q2]
14% less capital invested
Capital invested by funds: $380M [Q1] → $325M (-$55.1M) [Q2]
33% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 40
Research analyst outlook
6 Wall Street Analysts provided 1 year price targets over the past 3 months
6 analyst ratings
JP Morgan Anne Samuel 40% 1-year accuracy 2 / 5 met price target | 78%upside $13 | Overweight Maintained | 4 Sept 2024 |
Piper Sandler Jessica Tassan 50% 1-year accuracy 9 / 18 met price target | 51%upside $11 | Overweight Maintained | 26 Aug 2024 |
Cantor Fitzgerald Sarah James 67% 1-year accuracy 84 / 125 met price target | 119%upside $16 | Overweight Reiterated | 20 Aug 2024 |
Cantor Fitzgerald Sarah James 67% 1-year accuracy 84 / 125 met price target | 119%upside $16 | Overweight Reiterated | 9 Aug 2024 |
Stephens & Co. Jeff Garro 60% 1-year accuracy 3 / 5 met price target | 4%downside $7 | Equal-Weight Maintained | 8 Aug 2024 |